Tag Archives: KRAS

Promising Preclinical Results in Pancreatic Cancer

A recent announcement at the AACRs-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19–23, points to some promising results in recent trials that targeted multiple pathways downstream of KRAS (including PI3K/AKT, RAF/MEK/ERK and RAL).  The studies conducted … Continue reading

Posted in Cancer Research, Drug Development, pancreatic cancer | Tagged , , , | Leave a comment

Stunning News In Pancreatic Cancer Research

When Gleevec, the very first targeted therapeutic came out, there was a mad rush in the pharmaceutical industry to mine the genome for potential “magic bullet” targets.  In Gleevec’s case, it was able to inhibit the BCR-ABL fusion kinase, and … Continue reading

Posted in Cancer Research, Drug Development, pancreatic cancer, Science Blogging, Uncategorized | Tagged , , , | Leave a comment

New Pancreatic Genomics Papers

This weeks batch of papers includes an interesting review of the current treatments available for pancreatic cancer and their biomolecular targets.  We also have a number of papers on microRNA targets and their roles in sensitizing pancreatic cancer tumors to … Continue reading

Posted in pancreatic cancer | Tagged , , | Leave a comment